AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).

Biotechnology

AltPep

AltPep's headquarters in Seattle, WA, United States

Valerie Daggett

Amy C.

Jeff Posakony, Ph.D.

Jae Hyun Park

Nancy Hill

Gil Block

Patrik Edenholm

Charles Horne

Michael Levitt

David Goel

Alan Fersht

Jeff Roh

Joel S. Marcus

Todd Patrick

Roger Armen

Chad Robins

Research Associate, Diagnostics

Medical Laboratory Scientist

Description

People (13)

Valerie Daggett

Patrik Edenholm

Kurt Becker

Chad Robins

Nancy Hill

Calvin Fries

Jae Hyun Park

Jeff Posakony, Ph.D.

Albert Choi

Kekoa Knief

Melissa Booth, MLS(ASCP)CM

Amy C.

Carolyn Tallon

Jobs (2)

Research Associate, Diagnostics

Medical Laboratory Scientist